Saima Jehangir, MD
Obstetrics & Gynecology · Austin, TXNPI 1740256452
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 448 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 448 payments — averaging $25.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$2K
- AbbVie$2K
- Sumitomo Pharma America, Inc.$2K
- Axonics, Inc.$923
- Myovant Sciences Inc.$725
- Medtronic$468
- plus $3K from 31 others
Across 37 payments — averaging $2816.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$104K
What the payments were for
- Food & beverage$11,33799%
- Education$540%
- Gifts$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 26 | $2,176 |
| AbbVie(2 entities) | 118 | $2,083 |
| Sumitomo Pharma America, Inc. | 115 | $1,624 |
| Axonics, Inc. | 17 | $923 |
| Myovant Sciences Inc. | 43 | $725 |
| Medtronic(2 entities) | 14 | $468 |
| Mayne Pharma Commercial LLC | 13 | $450 |
| Shield Therapeutics Inc | 4 | $269 |
| Exeltis, USA Inc. | 11 | $261 |
| Galderma Laboratories, L.p. | 8 | $231 |
| Gynesonics, Inc. | 2 | $202 |
| Boston Scientific | 5 | $182 |
| Therapeuticsmd, Inc. | 11 | $177 |
| Valencia Technologies Corporation | 3 | $170 |
| Caldera Medical, Inc | 1 | $163 |
| Millicent US Inc | 9 | $153 |
| Bluewind Medical | 2 | $144 |
| Astellas Pharma US Inc | 7 | $133 |
| Convatec Inc. | 2 | $117 |
| Ascend Therapeutics US, LLC | 6 | $96 |
| Lupin Inc. | 5 | $93 |
| Hologic Sales And Service, LLC | 4 | $82 |
| Intuitive Surgical | 1 | $76 |
| Zyla Life Sciences, Inc. | 4 | $71 |
| AMAG Pharmaceuticals, Inc. | 3 | $54 |
| BD | 2 | $41 |
| Evofem Biosciences, Inc. | 2 | $38 |
| Coopersurgical, Inc. | 1 | $29 |
| 180 Medical, Inc. | 1 | $27 |
| Dilon Technologies, Inc. | 1 | $25 |
| Avanos Medical | 1 | $22 |
| Hollister Incorporated | 1 | $22 |
| Integra Lifesciences Corporation | 1 | $21 |
| Davol Inc. | 1 | $20 |
| Aspira Women's Health Inc | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Virtus Pharmaceuticals LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$852
- Axonics$381
- RESTORELLE$266
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM$181
- Desara$163
- Vertessa$163
- FEMALE INCONTINENCE$150
- INTERSTIM$142
- BOTOX$127
- Bulkamid$125
- Orilissa$122
- Twirla$106
- Slynd$106
- ACCRUFER$105
How this compares
$11,412 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 11 | $1,407 |
| ProgesteroneProgesterone, Micronized | 18 | $804 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Austin
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Renu ChalasaniAustin$156K
- Sharyl Brasher-GilesAustin$42K
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.